85666-15-5

Basic information

• Product Name: IFLAB-BB F2108-0078
• Synonyms: IFLAB-BB F2108-0078;4-PYRIDIN-3-YLMETHYL-PHENYLAMINE;4-(Pyridin-3-ylMethyl)aniline
• CAS NO: 85666-15-5
• Molecular Formula: C₁₂H₁₂N₂
• Molecular Weight: 184.24
• Mol File: 85666-15-5.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: IFLAB-BB F2108-0078(CAS DataBase Reference)
• NIST Chemistry Reference: IFLAB-BB F2108-0078(85666-15-5)
• EPA Substance Registry System: IFLAB-BB F2108-0078(85666-15-5)

Safety Data

• Hazardous Substances Data: 85666-15-5(Hazardous Substances Data)

Usage

General Description

IFLAB-BB F2108-0078, also known as 2-amino-3-carboxy-2,3-dihydro-1,4-oxazine, is a chemical compound with the molecular formula C4H7NO3. It is a derivative of oxazine, which is a six-membered heterocyclic ring compound. This chemical is commonly used in the synthesis of pharmaceuticals and agrochemicals, as well as in research and development. It has a range of potential applications due to its unique chemical structure and reactivity, and is a valuable building block in organic chemistry. However, it is important to handle and store IFLAB-BB F2108-0078 with care, as it may pose risks to human health and the environment if not managed properly.

Upstream product

• 32361-76-5 3-(4'-nitrobenzyl)pyridine 

Downstream Products

• 874367-72-3 3-(4-bromobenzyl)pyridine 
• 1062139-53-0 ethyl (2E)-2-(cyclopentylacetyl)-3-{[4-(pyridin-3-ylmethyl)phenyl]amino}acrylate 
• 1062139-48-3 ethyl (2E)-2-pentanoyl-3-{[4-(pyridin-3-ylmethyl)phenyl]amino}acrylate 
• 75987-20-1 3-(4'-Hydroxybenzyl)pyridine 
• 85666-17-7 furegrelate sodium 
• 85666-43-9 3-bromo-2-hydroxy-5-(3-pyridylmethyl)benzaldehyde 
• 85666-04-2 3-(3-formyl-4-hydroxybenzyl)pyridine 
• 91874-36-1 2,8-Di(pyridin-3-yl)methyl-13-phenyl-6H,12H-5,11-methanodibenzo[b,f][1,5]diazocine 

Relevant articles and documents

Affinity of 3-acyl substituted 4-quinolones at the benzodiazepine site of GABAA receptors

The finding that alkyl 1,4-dihydro-4-oxoquinoline-3-carboxylate and N-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxamide derivatives may be high-affinity ligands at the benzodiazepine binding site of the GABAA receptor, prompted a study of 3-acyl-1,4-dihydro-4-oxoquinoline (3-acyl-4-quinolones). In general, the affinity of the 3-acyl derivatives was found to be comparable with the 3-carboxylate and the 3-carboxamide derivatives, and certain substituents (e.g., benzyl) in position 6 were again shown to be important. As it is believed that the benzodiazepine binding site is situated between an α- and a γ-subunit in the GABAA receptor, selected compounds were tested on the α1β2γ2s, α2β2γ2s and α3β2γ2s GABAA receptor subtypes. The 3-acyl-4-quinolones display various degrees of selectivity for α1- versus α2- and α3-containing receptors, and high-affinity ligands essentially selective for α1 over α3 were developed.

INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS

Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.

Pyridyl-substituted-benzofurans

The present invention provides novel pyridinyl-benzofurans and derivatives thereof which are useful as thromboxane A2 (TXA2) synthetase inhibitors and as such represent potent pharmacological agents.